UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 654

Sortiert nach

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

Lancet neurology, 2013-10, Vol.12 (10), p.957-965

2013

Link zum Volltext

Verfügbarkeit prüfen

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease

Cell, 2017-08, Vol.170 (4), p.649-663.e13

2017

Link zum Volltext

Verfügbarkeit prüfen

Proteopathic tau seeding predicts tauopathy in vivo

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.E4376-E4385

2014

Link zum Volltext

Verfügbarkeit prüfen

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (44), p.18809-18814

2009

Link zum Volltext

Verfügbarkeit prüfen

The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy

Acta neuropathologica, 2016-01, Vol.131 (1), p.75-86

2016

Link zum Volltext

Verfügbarkeit prüfen

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Science translational medicine, 2016-05, Vol.8 (338), p.338ra66

2016

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls

Annals of neurology, 2013-01, Vol.73 (1), p.104-119

2013

Link zum Volltext

Verfügbarkeit prüfen

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Acta neuropathologica, 2012-01, Vol.123 (1), p.1-11

2012

Link zum Volltext

Verfügbarkeit prüfen

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

Alzheimer's & dementia, 2017-05, Vol.13 (5), p.561-571

2017

Link zum Volltext

Verfügbarkeit prüfen

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

NeuroImage (Orlando, Fla.), 2017-11, Vol.161, p.171-178

2017

Link zum Volltext

Verfügbarkeit prüfen

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging

Brain (London, England : 1878), 2016-08, Vol.139 (Pt 8), p.2249-2260

2016

Link zum Volltext

Verfügbarkeit prüfen

Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains

Scientific reports, 2016-12, Vol.6 (1), p.38187-38187, Article 38187

2016

Link zum Volltext

Verfügbarkeit prüfen

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Alzheimer's & dementia, 2012, Vol.8 (1), p.1-13

2012

Link zum Volltext

Verfügbarkeit prüfen

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Alzheimer's & dementia, 2017-04, Vol.13 (4), p.e1-e85

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy

JAMA neurology, 2016-09, Vol.73 (9), p.1070

2016

Link zum Volltext

Verfügbarkeit prüfen

Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics

The Journal of biological chemistry, 2019-01, Vol.294 (3), p.1045-1058

2019

Link zum Volltext

Verfügbarkeit prüfen

Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls

PloS one, 2018-07, Vol.13 (7), p.e0200251

2018

Link zum Volltext

Verfügbarkeit prüfen

The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy

Journal of neuropathology and experimental neurology, 2021-03, Vol.80 (3), p.210-219

2021

Link zum Volltext

Verfügbarkeit prüfen

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain

PloS one, 2012-11, Vol.7 (11), p.e49483-e49483

2012

Link zum Volltext

Verfügbarkeit prüfen

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

Alzheimer's & dementia, 2015-06, Vol.11 (6), p.e1-e120

2015

Link zum Volltext

Verfügbarkeit prüfen

The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses

Journal of neuropathology and experimental neurology, 2018-08, Vol.77 (8), p.717-726

2018

Link zum Volltext

Verfügbarkeit prüfen

Widespread tau seeding activity at early Braak stages

Acta neuropathologica, 2017-01, Vol.133 (1), p.91-100

2017

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

Science translational medicine, 2014-03, Vol.6 (226), p.226ra30

2014

Link zum Volltext

Verfügbarkeit prüfen

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

Nature neuroscience, 2018-02, Vol.21 (2), p.228

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 654

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(630)
Mit Volltextzugriff
(601)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(654)
Japanisch
(87)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease

Proteopathic tau seeding predicts tauopathy in vivo

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging

Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy

Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics

Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls

The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses

Widespread tau seeding activity at early Braak stages

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

Suchergebnisse filtern